By Admin at 13 Jul 2016
A new study showed that incorporating immunotherapy into ovarian cancer treatment might combat chemotherapy resistance and improve survival rates.
By Admin at 18 Jan 2016
Right now, researchers must use billions of T cells in adoptive cell therapy. However, a new “intelligent biogel” may change that, such that only millions of T cells would be required. Plus, the biogel shows promise in revolutionizing many cancer treatments.
58
Current Gateway-funded clinical trials
150+
Clinical trials funded at leading institutions worldwide
$16.56
Funds one patient for one day at a Gateway-funded clinical trial